Noun
natalizumab (uncountable)
(pharmacology) A humanized monoclonal antibody used in the treatment of multiple sclerosis and Crohn's disease.
As of May 2011, over 130 cases of PML had been reported in MS patients, all in patients who had taken natalizumab for more than a year. Source: Internet
The estimated prevalence of PML in MS is 1.5 cases per thousand natalizumab users. Source: Internet
Related to these investigations is the development of a test for JC virus antibodies, which might help to determine who is at greater risk of developing progressive multifocal leukoencephalopathy when taking natalizumab. Source: Internet